Jim Simons Phio Pharmaceuticals Corp. Transaction History

Renaissance Technologies LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.33 - $63.51 $15,444 - $2.97 Million	-46,800 Reduced 21.91%	166,800 $62,000
Q3 2022 Nov 14, 2022	SELL	$0.62 - $66.43 $13,174 - $1.41 Million	-21,249 Reduced 9.05%	213,600 $122,000
Q2 2022 Aug 12, 2022	BUY	$0.64 - $2.35 $123,743 - $454,370	193,349 Added 465.9%	234,849 $165,000
Q1 2022 May 13, 2022	BUY	$0.73 - $1.1 $22,922 - $34,540	31,400 Added 310.89%	41,500 $37,000
Q4 2021 Feb 11, 2022	BUY	$0.99 - $1.99 $9,999 - $20,099	10,100 New	10,100 $10,000
Q4 2020 Feb 10, 2021	SELL	$2.01 - $3.32 $40,802 - $67,396	-20,300 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$1.95 - $2.94 $105,069 - $158,413	-53,882 Reduced 72.63%	20,300 $43,000
Q2 2020 Aug 13, 2020	BUY	$1.68 - $3.05 $55,460 - $100,686	33,012 Added 80.18%	74,182 $162,000
Q1 2020 May 14, 2020	BUY	$1.77 - $12.93 $72,870 - $532,328	41,170 New	41,170 $73,000

Ticker PHIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,658,700
Market Cap $30.2M
Description
Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system. The company develops PH-762 that activates immune cells to recognize and kill cancer cells by reducing the expression of the checkpoint...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.